This page has beta status

BMBS COST Action BM0703
Cancer and Control of Genomic Integrity (CANGENIN)

The main objective of the Action is to advance our knowledge on mechanisms that protect healthy cells from transforming into cancer cells.

This Action will provide an interaction platform for research focused on genomic integrity and epigenetics and their dysregulation in cancer. The Action will combine expertise in the fields of DNA damage response, transcriptional control, chromatin organization, and cancer epigenetics, and explore the mechanisms underlying normal and deregulated functions. It will combine multidisciplinary expertise in biochemical, biological and functional genomics approaches and in exploiting animal models. The Action will link experts in basic sciences with approaches in translational cancer research. Due to the highest clinical significance of understanding of the molecular basis of cancer progression, it will be of vital importance for the European researchers to develop strong points of interaction to provide them with a competitive edge, new research models and tools in cancer research.

Keywords: DNA damage, repair, checkpoints, chromatin, transcription, translation, epigenetics, animal models

(Descriptions are provided by the Actions directly via e-COST.)


General Information*

Chair of the Action:

Dr Carina HOLMBERG-STILL (FI)

Vice Chair of the Action:

Prof. Bodil NORRILD (DK)

Science officer of the Action:

Dr Inga DADESHIDZE

Administrative officer of the Action:

Ms Gabriela CRISTEA

Downloads*

Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Progress Report

Download Progress Report as PDF

Poster

Download Poster as PDF

Websites*

* content provided by e-COST.
Data is synchronised once per night.

Tools

Last updated: 02 May 2011 top of page